Impact of beta-myosin heavy chain expression on cardiac function during stress - PubMed (original) (raw)
. 2004 Dec 21;44(12):2390-7.
doi: 10.1016/j.jacc.2004.09.044.
Affiliations
- PMID: 15607403
- DOI: 10.1016/j.jacc.2004.09.044
Free article
Impact of beta-myosin heavy chain expression on cardiac function during stress
Maike Krenz et al. J Am Coll Cardiol. 2004.
Free article
Abstract
Objectives: In failing mouse and human hearts, a shift in myosin heavy chain (MHC) isoform content from alpha to beta can occur. However, the impact of this phenomenon on disease progression is not well understood. Therefore, using transgenic (TG) mice, we tested how a pre-existing shift from alpha- to beta-MHC affects cardiac function under chronic mechanical or pharmacologic cardiovascular stress.
Background: Expression of beta-MHC is considered to be energetically favorable, but this might be offset by depressed cardiac function.
Methods: Transgenic mice with near-complete replacement of the normally predominant alpha- with beta-MHC were subjected to cardiac stress.
Results: At baseline, TG mice show moderately reduced cardiac contractile function but are otherwise healthy with normal ventricular morphology. After four weeks of swimming, both TG and non-TG animals showed a 20% increase in left ventricular (LV)/body weight ratios. The TG hearts displayed mildly greater end-diastolic and end-systolic LV diameters than nontransgenic hearts after training, but no signs of LV failure were observed. However, chronic stimulation with isoproterenol resulted in augmented LV hypertrophy with signs of LV decompensation in TG mice. Furthermore, in a post-infarction failure model, TG hearts displayed accelerated LV dilation and a faster decline of shortening fraction.
Conclusions: Expression of beta-MHC appears to be disadvantageous to the mice under severe cardiovascular stress, implying that the alpha-->beta-MHC isoform shift observed in cardiac disease may be a maladaptive response.
Similar articles
- Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ, Scott NJ, Cameron VA, Richards AM, Rademaker MT. Ellmers LJ, et al. J Cardiovasc Pharmacol. 2015 Mar;65(3):269-75. doi: 10.1097/FJC.0000000000000190. J Cardiovasc Pharmacol. 2015. PMID: 25658462 - Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions.
James J, Martin L, Krenz M, Quatman C, Jones F, Klevitsky R, Gulick J, Robbins J. James J, et al. Circulation. 2005 May 10;111(18):2339-46. doi: 10.1161/01.CIR.0000164233.09448.B1. Epub 2005 May 2. Circulation. 2005. PMID: 15867177 Free PMC article. - Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment.
Sabbah HN, Sharov VG, Gupta RC, Mishra S, Rastogi S, Undrovinas AI, Chaudhry PA, Todor A, Mishima T, Tanhehco EJ, Suzuki G. Sabbah HN, et al. Circ Res. 2003 Nov 28;93(11):1095-101. doi: 10.1161/01.RES.0000101932.70443.FE. Epub 2003 Oct 16. Circ Res. 2003. PMID: 14563716 - Induction of S100b in myocardium: an intrinsic inhibitor of cardiac hypertrophy.
Parker TG, Marks A, Tsoporis JN. Parker TG, et al. Can J Appl Physiol. 1998 Aug;23(4):377-89. doi: 10.1139/h98-022. Can J Appl Physiol. 1998. PMID: 9677434 Review.
Cited by
- Cardiomyocyte-specific overexpression of HEXIM1 prevents right ventricular hypertrophy in hypoxia-induced pulmonary hypertension in mice.
Yoshikawa N, Shimizu N, Maruyama T, Sano M, Matsuhashi T, Fukuda K, Kataoka M, Satoh T, Ojima H, Sawai T, Morimoto C, Kuribara A, Hosono O, Tanaka H. Yoshikawa N, et al. PLoS One. 2012;7(12):e52522. doi: 10.1371/journal.pone.0052522. Epub 2012 Dec 31. PLoS One. 2012. PMID: 23300697 Free PMC article. - miR-206 enforces a slow muscle phenotype.
Bjorkman KK, Guess MG, Harrison BC, Polmear MM, Peter AK, Leinwand LA. Bjorkman KK, et al. J Cell Sci. 2020 Aug 11;133(15):jcs243162. doi: 10.1242/jcs.243162. J Cell Sci. 2020. PMID: 32620696 Free PMC article. - Repression of the Central Splicing Regulator RBFox2 Is Functionally Linked to Pressure Overload-Induced Heart Failure.
Wei C, Qiu J, Zhou Y, Xue Y, Hu J, Ouyang K, Banerjee I, Zhang C, Chen B, Li H, Chen J, Song LS, Fu XD. Wei C, et al. Cell Rep. 2015 Mar 10;10(9):1521-1533. doi: 10.1016/j.celrep.2015.02.013. Epub 2015 Mar 5. Cell Rep. 2015. PMID: 25753418 Free PMC article. - Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy.
Calligaris SD, Lecanda M, Solis F, Ezquer M, Gutiérrez J, Brandan E, Leiva A, Sobrevia L, Conget P. Calligaris SD, et al. PLoS One. 2013 Apr 11;8(4):e60931. doi: 10.1371/journal.pone.0060931. Print 2013. PLoS One. 2013. PMID: 23593350 Free PMC article. - Myosin 7b is a regulatory long noncoding RNA (lncMYH7b) in the human heart.
Broadwell LJ, Smallegan MJ, Rigby KM, Navarro-Arriola JS, Montgomery RL, Rinn JL, Leinwand LA. Broadwell LJ, et al. J Biol Chem. 2021 Jan-Jun;296:100694. doi: 10.1016/j.jbc.2021.100694. Epub 2021 Apr 22. J Biol Chem. 2021. PMID: 33895132 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous